688278 特宝生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)4.64734.35837.36633.82822.346
总资产报酬率 ROA (%)3.72327.78130.61526.92517.972
投入资产回报率 ROIC (%)4.26032.07435.66032.27721.400

边际利润分析
销售毛利率 (%)89.45492.96593.48693.33288.916
营业利润率 (%)24.89833.84234.45832.41026.650
息税前利润/营业总收入 (%)22.46531.74832.97130.27423.037
净利润/营业总收入 (%)20.61927.90529.37726.44618.797

收益指标分析
经营活动净收益/利润总额(%)105.665103.317100.511103.762101.885
价值变动净收益/利润总额(%)0.9290.8550.5300.9671.101
营业外收支净额/利润总额(%)-10.944-6.404-4.265-6.254-14.328

偿债能力分析
流动比率 (X)4.7913.8614.3443.3203.567
速动比率 (X)4.0503.2753.7172.8573.083
资产负债率 (%)18.66321.12616.29620.35920.469
带息债务/全部投入资本 (%)5.3135.3751.3441.194-2.475
股东权益/带息债务 (%)1,726.7961,704.6787,125.5677,950.842-3,880.651
股东权益/负债合计 (%)435.809373.354513.644391.173388.546
利息保障倍数 (X)993.401-561.531-426.964-132.170-84.160

营运能力分析
应收账款周转天数 (天)113.61989.65477.26856.12547.562
存货周转天数 (天)452.329469.713441.944407.086261.874